(Press-News.org) Houston, TX – New research by a team at Pennsylvania State University suggests that microbes in the human gut could be harnessed to block absorption of toxic metals like mercury and help the body absorb useful nutritional ones, like iron. The group presents their findings at ASM Microbe 2023, the annual meeting of the American Society for Microbiology.
Methylmercury, a neurotoxin, is particularly worrisome, said Daniela Betancurt-Anzola, a graduate student at Penn State who led the new study. It has a variety of toxic effects, and it is detrimental for neurological development during pregnancy and childhood, particularly in communities heavily reliant on fish-based diets. Most methylmercury exposure is through fish or shellfish, but it can show up elsewhere as well. “It accumulates in living things, in plants and fish,” she said. “We eat those things, and it accumulates in us.”
Betancurt-Anzola and her colleagues first analyzed thousands of genomes from gut bacteria, focusing on genetic determinants associated with the ability to interact with metals. Many genes are known to be connected to metal resistance, she said, but the group focused on those that enable bacteria to convert dangerous mercury to less toxic forms and absorb the heavy metal.
To understand how those genes function and impact the host, the team used metagenomic sequencing to study how human and mouse microbes responded to mercury exposure. Finally, the investigators used those insights to develop a probiotic specifically designed to detoxify a harmful type of mercury often found in the human diet. They inserted genes from Bacillus megaterium bacteria, which is known to be highly resistant to methylmercury, into strains of Lacticaseibacillus, a genus of lactic acid bacteria.
“It’s a perfect probiotic for this because we have previously shown it works in humans, and now we are engineering it to make it even better,” Betancurt-Anzola said. “It is inside the gut, it grabs the methylmercury, then it goes out.”
For now, she said, the group is focused on understanding how gut microbes interact with mercury, but they plan to investigate other metals as well. Their ultimate goal is to develop interventions that could help reduce levels of dangerous metals — like mercury — and boost absorption of those that the human body needs. “We are interested in studying how the entire microbial community reacts to different metals,” Betancurt-Anzola said.
###
ASM Microbe is the annual meeting of the American Society for Microbiology, held June 15-19, 2023, in Houston, Texas.
The American Society for Microbiology is one of the largest professional societies dedicated to the life sciences and is composed of 30,000 scientists and health practitioners. ASM's mission is to promote and advance the microbial sciences.
ASM advances the microbial sciences through conferences, publications, certifications, educational opportunities and advocacy efforts. It enhances laboratory capacity around the globe through training and resources. It provides a network for scientists in academia, industry and clinical settings. Additionally, ASM promotes a deeper understanding of the microbial sciences to diverse audiences.
END
A probiotic could help mitigate mercury absorption in the gut
2023-06-18
ELSE PRESS RELEASES FROM THIS DATE:
An oral probiotic can treat dry eye disease
2023-06-18
Houston, TX – In a study by a research group at Baylor College of Medicine, oral administration of a commercially available probiotic bacterial strain was found to improve dry eye disease in an animal model. The findings were presented at ASM Microbe 2023, the annual meeting of the American Society for Microbiology.
Dry eye, a common condition in which tears produced by the eye can’t keep the eye adequately lubricated, afflicts approximately 1 in 20 people in the United States. It can cause eye stinging and burning, inflammation, blurry vision and light sensitivity. Extreme cases can result in damage ...
People with alcohol use disorder impaired after heavy drinking, despite claims of higher tolerance
2023-06-18
While heavy drinkers can tolerate a certain amount of alcohol better than light or moderate drinkers, the concept of “holding your liquor” is more nuanced than commonly believed, according to new research from the University of Chicago.
The researchers conducted the study with three groups of young adults in their 20s with different drinking patterns. They found that drinkers with alcohol use disorder (or AUD, traditionally known as alcoholism) displayed less impairment on fine motor and cognitive tasks than light or heavy social drinkers after consuming a standard intoxicating dose—equivalent ...
Social isolation linked to reduced bone quality in males, mouse study finds
2023-06-18
Social isolation may negatively impact bone health, suggests a study conducted in mice being presented Sunday at ENDO 2023, the Endocrine Society’s annual meeting in Chicago, Ill.
“Social isolation is a potent form of psychosocial stress and is a growing public health concern, particularly among older adults,” said lead researcher Rebecca Mountain, Ph.D., of MaineHealth Institute for Research in Scarborough, Maine. “Even prior to the onset of the COVID-19 pandemic, which has significantly increased the prevalence of isolation and loneliness, researchers have been concerned about a rising ‘epidemic ...
Prompt testosterone treatment improves mental health of transgender, gender-diverse people
2023-06-18
Receiving rapid access to testosterone therapy reduced feelings of gender dysphoria and led to a clinically significant reduction in depression as well as a 50% reduction in suicidality among transgender and gender diverse adults, according to research being presented Sunday at ENDO 2023, the Endocrine Society’s annual meeting in Chicago, Ill.
“This is the world-first randomized clinical trial supporting the significant benefits of testosterone in reducing gender dysphoria, depression and suicidality in trans individuals desiring commencement of testosterone,” said Brendan Nolan, M.B.B.S., F.R.A.C.P., a Ph.D. candidate at ...
Single hospital study finds transgender teenagers rarely choose to discontinue hormone therapy
2023-06-18
A three-year-long retrospective cohort study of a single Atlanta hospital’s patient population found transgender and gender-diverse teenagers rarely chose to discontinue gender-affirming hormone therapy, according to a study being presented Sunday at ENDO 2023, the Endocrine Society’s annual meeting in Chicago, Ill.
Among 82 transgender and gender-diverse adolescents treated at an academic pediatric endocrinology center from beginning of 2016 to end of 2018, only three chose to halt gender-affirming hormone therapy. None of them resumed identifying as their assigned sex at birth. One participant stopped hormonal therapy due to insurance ...
Radioactive iodine or surgery associated with increased survival in hyperthyroidism
2023-06-17
Hyperthyroidism treatment like radioactive iodine or surgery was associated with a decreased risk for death, according to research being presented Saturday at ENDO 2023, the Endocrine Society’s annual meeting in Chicago.
“Hyperthyroidism or an overactive thyroid gland is common, affecting up to 3% of the population, and is associated with long-term adverse cardiac and metabolic consequences. The optimal treatment choice remains unclear,” said Kristien Boelaert, M.D., Ph.D., a professor of endocrinology from the University of Birmingham in the United Kingdom.
Boelaert and colleagues identified 55,318 patients ...
Drug-resistant Candida auris infection rates continue to rise
2023-06-17
Houston, TX – Candida auris, an emerging fungal pathogen resistant to many antimicrobial agents, continues to threaten U.S. public health. Researchers at bioMérieux Inc. conducted a retrospective analysis of blood cultures positive for C. auris and found an upsurge in detection of this pathogenic yeast between 2021 and 2023. The average detection rate of 0.014% before October 2022 (July 2020 to September 2022) rose to 0.057% after October 2022 (October 2022 to March 2023). They presented their findings at ASM Microbe 2023, the annual meeting of the American Society for Microbiology.
The researchers investigated changes in C. auris infection rates geographically and over ...
Treatment with enzyme inhibitor can help combat antimicrobial resistance
2023-06-17
Houston, TX – New research by investigators in Ghent, Belgium shows that intravenous treatment with MK-3402, a metallo-beta-lactamase inhibitor, can be an effective strategy in fighting antimicrobial resistance. The findings are presented at ASM Microbe 2023, the annual meeting of the American Society for Microbiology.
Antimicrobial resistance is a major threat to public health. Some bacteria are resistant to treatment because they produce the enzyme metallo-beta-lactamase, which make a certain class ...
Better tests needed to identify Candida auris susceptibility
2023-06-17
Houston, TX – Matching an infection with Candida auris, a pathogenic yeast, to an effective antifungal is a critical clinical decision. That decision relies on susceptibility testing, but commercially available antifungal tests perform poorly for many treatments, researchers at Indiana University and Indiana University Health have found. The investigators, who tested the accuracy of 4 available tests for use with C. auris, present their findings at ASM Microbe 2023, the annual meeting of the American Society for Microbiology.
C. ...
Transgender people seen in the ER much more likely than cisgender people to be admitted to hospital
2023-06-17
Transgender people who come to the emergency room for care tend to be sicker than cisgender people who are otherwise similar to them and are much more likely to be admitted to the hospital once they visit the ER, according to a study being presented Saturday at ENDO 2023, the Endocrine Society’s annual meeting in Chicago, Ill.
“Our findings suggest that decreasing discrimination against transgender people in society and in health care, and improving the outpatient care they are able to access in the community, may keep them healthier and help them avoid visits to the ER,” said lead researcher Daphna Stroumsa, ...